PKTX
ProtoKinetix, Incorporated
Price Chart
Latest Quote
$0.01
+0.00 (+8.08%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 170,965 |
Stock Information
| Shares Outstanding | 391.58M |
| Cash Equivalents | $607 |
| Net Income | $-376K |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $2.20M |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.04M |
| Income | $-376K |
| Book/sh | $0.00 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.00 |
| Current Ratio | 0.01 |
Returns & Margins
| ROA | -49.14% |
| ROE | -117.19% |
Ownership
| Insider Ownership | 37.68% |
| Institutional Ownership | 0.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 5.62 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.01 |
| SMA50 | $0.01 |
| SMA200 | $0.01 |
| RSI | 45.52 |
| ATR | 0.0002 |
| Shares Float | 332.68M |
| Volatility | 0.75 |
| Rel Volume | 8.72 |
Performance History
| Week | +8.08% |
| Month | +4.07% |
| Quarter | +12.40% |
| 6 Months | +17.08% |
| YTD | -13.54% |
| Year | -37.56% |
| 3 Years | -75.57% |
| 5 Years | -96.59% |
| 10 Years | -91.95% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.01 | 272,915 |
| 2026-06-17 | $0.01 | 0 |
| 2026-06-16 | $0.01 | 0 |
| 2026-06-15 | $0.01 | 0 |
| 2026-06-12 | $0.01 | 0 |
| 2026-06-11 | $0.01 | 0 |
| 2026-06-10 | $0.01 | 0 |
| 2026-06-09 | $0.01 | 100,949 |
| 2026-06-08 | $0.01 | 0 |
| 2026-06-05 | $0.01 | 0 |
| 2026-06-04 | $0.01 | 10,000 |
| 2026-06-03 | $0.01 | 0 |
| 2026-06-02 | $0.01 | 0 |
| 2026-06-01 | $0.01 | 117,000 |
| 2026-05-29 | $0.01 | 0 |
| 2026-05-28 | $0.01 | 0 |
| 2026-05-27 | $0.01 | 0 |
| 2026-05-26 | $0.01 | 5,000 |
| 2026-05-22 | $0.01 | 0 |
| 2026-05-21 | $0.01 | 120,000 |
| 2026-05-20 | $0.01 | 6,800 |
| 2026-05-19 | $0.01 | 0 |
About ProtoKinetix, Incorporated
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
đ° Latest News
No news articles available at the moment. Check back later for updates on PKTX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $364,188 | $415,479 | $1,907,309 | $2,329,310 |
| Operating Expense | $364,188 | $415,479 | $1,907,309 | $2,329,310 |
| General And Administrative Expense | $211,693 | $254,776 | $1,399,986 | $1,890,438 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Normalized Income | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Net Income From Continuing And Discontinued Operation | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Net Income Common Stockholders | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Net Income | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Net Income Including Noncontrolling Interests | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Net Income Continuous Operations | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Pretax Income | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Operating Income | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Depreciation Amortization Depletion Income Statement | $52,870 | $48,259 | $58,450 | $3,000 |
| Depreciation And Amortization In Income Statement | $52,870 | $48,259 | $58,450 | $3,000 |
| Amortization Of Intangibles Income Statement | $52,870 | $48,259 | $58,450 | $3,000 |
| Per Share | ||||
| Diluted EPS | $0.00 | $-0.01 | $-0.01 | $-0.01 |
| Basic EPS | $0.00 | $-0.01 | $-0.01 | $-0.01 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-311,318 | $-367,220 | $-1,848,859 | $-2,326,310 |
| Reconciled Depreciation | $52,870 | $48,258 | $58,450 | $3,000 |
| EBITDA (Bullshit earnings) | $-311,318 | $-367,220 | $-1,848,859 | $-2,326,310 |
| EBIT | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Diluted Average Shares | $358,557,930 | $333,102,754 | $307,392,069 | $291,865,922 |
| Basic Average Shares | $358,557,930 | $333,102,754 | $307,392,069 | $291,865,922 |
| Diluted NI Availto Com Stockholders | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
| Amortization | $52,870 | $48,259 | $58,450 | $3,000 |
| Research And Development | $99,625 | $112,444 | $448,873 | $435,872 |
| Selling General And Administration | $211,693 | $254,776 | $1,399,986 | $1,890,438 |
| Other Gand A | $206,276 | $254,776 | $329,003 | $477,383 |
| Salaries And Wages | $5,417 | $0 | $1,070,983 | $1,413,055 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-127,694 | $-23,238 | $-14,930 | $-9,705 |
| Total Assets | $466,137 | $480,557 | $462,870 | $446,234 |
| Total Non Current Assets | $469,784 | $459,099 | $436,270 | $362,671 |
| Goodwill And Other Intangible Assets | $469,784 | $459,099 | $436,270 | $362,671 |
| Other Intangible Assets | $469,784 | $459,099 | $436,270 | $362,671 |
| Current Assets | $-3,647 | $21,458 | $26,600 | $83,563 |
| Prepaid Assets | $1,050 | $1,050 | $1,050 | $25,995 |
| Cash Cash Equivalents And Short Term Investments | $-4,697 | $20,408 | $25,550 | $57,568 |
| Cash And Cash Equivalents | $-4,697 | $20,408 | $25,550 | $57,568 |
| Cash Financial | $-4,697 | $20,408 | $25,550 | $57,568 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $124,047 | $44,696 | $41,530 | $93,268 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $124,047 | $44,696 | $41,530 | $93,268 |
| Payables And Accrued Expenses | $124,047 | $44,696 | $41,530 | $93,268 |
| Equity | ||||
| Common Stock Equity | $342,090 | $435,861 | $421,340 | $352,966 |
| Total Equity Gross Minority Interest | $342,090 | $435,861 | $421,340 | $352,966 |
| Stockholders Equity | $342,090 | $435,861 | $421,340 | $352,966 |
| Retained Earnings | $-48,228,146 | $-47,863,958 | $-47,448,479 | $-45,541,170 |
| Other | ||||
| Ordinary Shares Number | $371,880,152 | $346,213,485 | $322,880,151 | $297,393,485 |
| Share Issued | $371,880,152 | $346,213,485 | $322,880,151 | $297,393,485 |
| Tangible Book Value | $-127,694 | $-23,238 | $-14,930 | $-9,705 |
| Invested Capital | $342,090 | $435,861 | $421,340 | $352,966 |
| Working Capital | $-127,694 | $-23,238 | $-14,930 | $-9,705 |
| Total Capitalization | $342,090 | $435,861 | $421,340 | $352,966 |
| Additional Paid In Capital | $48,568,249 | $48,297,969 | $47,868,093 | $45,892,545 |
| Capital Stock | $1,987 | $1,850 | $1,726 | $1,591 |
| Common Stock | $1,987 | $1,850 | $1,726 | $1,591 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-281,105 | $-435,142 | $-936,718 | $-980,876 |
| Operating Activities | ||||
| Operating Cash Flow | $-223,050 | $-375,989 | $-804,669 | $-889,891 |
| Cash Flow From Continuing Operating Activities | $-223,050 | $-375,989 | $-804,669 | $-889,891 |
| Investing Activities | ||||
| Capital Expenditure | $-58,055 | $-59,153 | $-132,049 | $-90,985 |
| Investing Cash Flow | $-58,055 | $-59,153 | $-132,049 | $-90,985 |
| Cash Flow From Continuing Investing Activities | $-58,055 | $-59,153 | $-132,049 | $-90,985 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $256,000 | $430,000 | $904,700 | $845,000 |
| Financing Cash Flow | $256,000 | $430,000 | $904,700 | $845,000 |
| Cash Flow From Continuing Financing Activities | $256,000 | $430,000 | $904,700 | $845,000 |
| Net Common Stock Issuance | $256,000 | $430,000 | $904,700 | $845,000 |
| Common Stock Issuance | $256,000 | $430,000 | $904,700 | $845,000 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $-4,697 | $20,408 | $25,550 | $57,568 |
| Beginning Cash Position | $20,408 | $25,550 | $57,568 | $193,445 |
| Changes In Cash | $-25,105 | $-5,142 | $-32,018 | $-135,877 |
| Net Intangibles Purchase And Sale | $-58,055 | $-59,153 | $-132,049 | $-90,985 |
| Purchase Of Intangibles | $-58,055 | $-59,153 | $-132,049 | $-90,985 |
| Change In Working Capital | $82,851 | $-8,768 | $-26,793 | $23,364 |
| Change In Payables And Accrued Expense | $82,851 | $-8,768 | $-51,738 | $48,309 |
| Change In Prepaid Assets | $0 | $0 | $24,945 | $-24,945 |
| Stock Based Compensation | $5,417 | $0 | $1,070,983 | $1,413,055 |
| Depreciation Amortization Depletion | $52,870 | $48,258 | $58,450 | $3,000 |
| Depreciation And Amortization | $52,870 | $48,258 | $58,450 | $3,000 |
| Amortization Cash Flow | $52,870 | $48,258 | $58,450 | $3,000 |
| Amortization Of Intangibles | $52,870 | $48,258 | $58,450 | $3,000 |
| Net Income From Continuing Operations | $-364,188 | $-415,479 | $-1,907,309 | $-2,329,310 |
Fetched: 2026-02-02